Nationwide Recall of Heart Medication Due to Foreign Pills

Advagen Pharma Limited has initiated a nationwide recall of over 3.6 million tablets of metoprolol tartrate, a commonly prescribed heart medication, after the discovery that some bottles may contain unidentified foreign tablets or capsules. The recall, which began on October 27, 2026, received a Class II classification from the U.S. Food and Drug Administration on November 10, 2026.